Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02519738 · ClinicalTrials.gov registry record · Phase 3
Granulation Tissue Treatment: Silver Nitrate vs Kenalog vs Washcloth Abrasion
A Phase 3 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 3
- Development phase
- 52
- Enrollment target
NCT02519738 is a Phase 3 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 52 participants.
The verdict
NCT02519738, a Phase 3 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 52 participants
- Enrollment target
Study Summary
Granulation tissue, or excess tissue, forms around gastrostomy tube sites and is a common problem seen in the pediatric surgery population. There is no standard treatment that has been identified in clinical practice to treat granulation tissue effectively. Clinicians prescribe treatments of varying nature to help treat this condition. By conducting this study, the investigators hope to identify if there is any difference in the treatment groups and if there is any superiority for one treatment over the other. The three arms in the study are Silver Nitrate treatment, treatment with Kenalog, and Washcloth abrasion. Treatments will continue over a period of three weeks, and the progress will be followed using surveys and photographs.
Interventions
- DRUG Silver Nitrate
- DRUG Kenalog (Triamcinolone)
- OTHER Washcloth Abrasion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2015-01-15 |
| Est. Completion | 2018-11-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02519738
The ClinicalTrials.gov registry entry for NCT02519738 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Silver Nitrate is the first listed.
NCT02519738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02519738 about?
NCT02519738 is a clinical study titled "Granulation Tissue Treatment: Silver Nitrate vs Kenalog vs Washcloth Abrasion". Granulation tissue, or excess tissue, forms around gastrostomy tube sites and is a common problem seen in the pediatric surgery population. There is no standard treatment that has been identified in clinical practice to treat granulation tissue effectively. Clinicians prescribe treatments of varying...
What is the current status of trial NCT02519738?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 52 participants. The study started on 2015-01-15. Estimated completion is 2018-11-13.
What interventions are being tested in trial NCT02519738?
The interventions under investigation include: Silver Nitrate (DRUG), Kenalog (Triamcinolone) (DRUG), Washcloth Abrasion (OTHER).
Who is sponsoring clinical trial NCT02519738?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.